meglutol

This page covers all meglutol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Targets

3-hydroxy-3-methylglutaryl-coenzyme A reductase

Phase 2 pipeline (1)

• Mevalon · Metabolic
  Mevalon works by blocking an enzyme that helps produce cholesterol in the liver.

Patent intelligence

• meglutol patent landscape — aggregated cliff calendar, attackable patents, originator estates